Capacity Management

Novartis May Counter Crucell Offer for Berna Biotech (Update2)  Bloomberg.com - Dec 18 3:06 PM Dec. 18 (Bloomberg) — Novartis AG, Europe’s second-biggest drugmaker by market value, said it may expand its Chiron Corp. vaccines business with a counter-bid for Berna Biotech AG, which Crucell NV agreed to buy earlier this month.Save to My Web
Students need […] more…

Capacity Management

This entry was posted on Friday, December 23rd, 2005 at 3:47 pm and is filed under Capacity Management. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.